Key facts
- It has raised $9.2M; the latest was Early Stage VC in Feb 2025.
- Notable investors include Transpose Platform Management, Jeff Dean, Kindred Ventures, Delphi Ventures, Upfront Ventures — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Sophont
- ·The full record, as it builds
Funding rounds
No funding rounds for Sophont are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sophont
Developer of open-source medical artificial intelligence models designed to integrate diverse medical data types for various healthcare applications. The company offers models to handle patient histories, pathology slides, and brain scans, supporting tasks like identifying biomarkers, improving clinical trial patient selection, summarizing patient data for doctors, and creating medical summaries to release model weights and training details, enabling customers to identify biomarkers, improve patient selection for clinical trials, and create patient-facing electronic health record interfaces for healthcare management.
- Sector
- Healthcare
- HQ
- Dover, DE, United States
- Founded
- 2025
- Employees
- 3
- Website
- sophontai.com/
- Ownership
- Privately Held (backing)
Sophont doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sophont shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sophont in its N-PORT filings yet. We sweep new filings monthly.